Human Oncology & Pathogenesis Program

The Adrienne Boire Lab

Research

Adrienne A. Boire
Adrienne A. Boire, MD, PhD
Scientific Director, Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center

Associate Professor

The Boire lab studies leptomeningeal metastasis as a means to understand the principles of metastasis as well as the nervous system’s relationship to the larger organism.

View Lab Overview

The Adrienne Boire Lab Members

Publications Highlights

Remsik J, and A Boire. 2024 The path to leptomeningeal metastasis. Nat Rev Cancer. 24(7):448-460.

Tong X, Remsik J, Brook J, Petrova B, Xu L, Li MJ, Snyder J, Chabot K, Estrera R, Osei-Gyening I, Nobre AR, Wang H, Osman AM, Wong AYL, Sidharta M, Piedrafita-Ortiz S, Manoranjan B, Zhou T, Murali R, Hamard PJ, Koche R, He Y, Kanarek N, and A Boire 2024 Retinoid X Receptor Signaling Mediates Cancer Cell Lipid Metabolism in the Leptomeninges. bioRxiv doi: 10.1101/2024.10.13.618083

Wilcox JA, Chukwueke UN, Ahn MJ, Aizer AA, Bale TA, Brandsma D, Brastianos PK, Chang S, Daras M, Forsyth P, Garzia L, Glantz M, Oliva ICG, Kumthekar P, Le Rhun E, Nagpal S, O’Brien B, Pentsova E, Lee EQ, Remsik J, Rudà R, Smalley I, Taylor MD, Weller M, Wefel J, Yang JT, Young RJ, Wen PY, Boire AA 2024 Leptomeningeal metastases from solid tumors: A SNO and ASCO consensus review on clinical management and future directions. Neuro Oncol. 26(10):1781-1804.

Remsik J, Tong X, Kunes RZ, Li MJ, Osman A, Chabot K, Sener UT, Wilcox JA, Isakov D, Snyder J, Bale TA, Chaligné R, Pe’er D, and A Boire. 2023 Leptomeningeal anti-tumor immunity follows unique signaling principles. bioRxiv. doi: 10.1101/2023.03.17.533041. Preprint.

Umemura Y, Khan B, Weill BJ, Buthorn JJ, Skakodub A, Ridder AJ, Nevel KS, Sun Y, and A Boire 2022 Discordance between perceptions and experience of lumbar puncture: A prospective study. Neurol Clin Pract 12(5):344-351.

View All Publications

People

Adrienne A. Boire

Adrienne A. Boire, MD, PhD

Scientific Director, Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center

Associate Professor

  • Physician-scientist Adrienne Boire studies metastasis to the central nervous system.
  • PhD, Tufts University, Boston, MA
  • MD, University of Chicago, Chicago, IL
646-888-3861
Office Phone
View physician profile
Physician profile

Members

Research Technician
Lea Doerries
Research Technician
Weill Cornell Graduate Student
Branavan Manoranjan
Research Fellow
Sierra Norfleet
Administrative Assistant
Jenna Snyder
GSK Graduate Student
Seogho Son
Research Scholar
GSK Graduate Student
Xinran Tong
Weil Cornell Graduate Student
Research Technician
Research Technician
Senior Research Technician
Giscard Barbier
Administrative Assistant
Kiana Chabot
Research Technician
Research Scholar
Samantha De La Moneda
Administrative Assistant
Laboratory Technician
Rachel Estrera
Research Technician
Morgan Freret
Research Fellow
David Gruber
Research Technician
Sara Haddock
Graduate Student, Cornell BCMB
Danielle Isakov
Research Technician
Min Jun Li
Research Technician
Anestashia Melford
Administrative Assistant
Isaiah Osei-Gyening
Research Technician
Ahmed Osman
Visiting Investigator
Sofia Piedrafita-Ortiz
MSK Bridge Program Scholar
Research Technician
Jan Remsik, PharmD, PhD
Senior Research Scientist
Fadi Saadeh
Research Fellow
Ugur Sener
Clinical Fellow
Administrative Assistant
Administrative Assistant
Helen Wang
Research Technician
Jessica Wilcox
Assistant Attending Neurologist

Achievements

  • 2021 Geoffrey Beene Junior Faculty Chair
  • American Academy of Neurology Neuro Oncology Investigator Award (2020)
  • Pershing Square Sohn Prize (2019)
  • Pew Biomedical Scholar (2018)
  • Damon Runyon Clinical Investigator Award (2017)

Open Positions

To learn more about available postdoctoral opportunities, please visit our Career Center

To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs

General Opportunities

Apply now

Get in Touch

Disclosures

Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.

Adrienne A. Boire discloses the following relationships and financial interests:

  • American Association for Cancer Research
    Professional Services and Activities (Uncompensated)
  • Baptist Health Miami Cancer Institute
    Professional Services and Activities
  • Cancer Research UK
    Professional Services and Activities (Uncompensated)
  • Gordon Research Conferences
    Professional Services and Activities (Uncompensated)
  • MD Anderson
    Professional Services and Activities (Uncompensated)
  • National Brain Tumor Society
    Professional Services and Activities (Uncompensated)
  • Providence Brain and Spine Institute
    Professional Services and Activities (Uncompensated)
  • Society for Neuro-Oncology (SNO)
    Fiduciary Role / Position; Professional Services and Activities
  • Stanford University
    Professional Services and Activities (Uncompensated)
  • UCSF Helen Diller Family Comprehensive Cancer Center
    Professional Services and Activities (Uncompensated)
  • University of Hamburg
    Professional Services and Activities (Uncompensated)
  • VIB-KU Leuven Center for Cancer Biology
    Professional Services and Activities (Uncompensated)

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures